1xw7: Difference between revisions

New page: left|200px<br /> <applet load="1xw7" size="450" color="white" frame="true" align="right" spinBox="true" caption="1xw7, resolution 2.30Å" /> '''Diabetes-Associated...
 
No edit summary
Line 1: Line 1:
[[Image:1xw7.gif|left|200px]]<br />
[[Image:1xw7.gif|left|200px]]<br /><applet load="1xw7" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1xw7" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1xw7, resolution 2.30&Aring;" />
caption="1xw7, resolution 2.30&Aring;" />
'''Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies of A-Chain Variant Insulin Wakayama'''<br />
'''Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies of A-Chain Variant Insulin Wakayama'''<br />


==Overview==
==Overview==
Naturally occurring mutations in insulin associated with diabetes mellitus, identify critical determinants of its biological activity. Here, we, describe the crystal structure of insulin Wakayama, a clinical variant in, which a conserved valine in the A chain (residue A3) is substituted by, leucine. The substitution occurs within a crevice adjoining the classical, receptor-binding surface and impairs receptor binding by 500-fold, an, unusually severe decrement among mutant insulins. To resolve whether such, decreased activity is directly or indirectly mediated by the variant side, chain, we have determined the crystal structure of Leu(A3)-insulin and, investigated the photo-cross-linking properties of an A3 analogue, containing p-azidophenylalanine. The structure, characterized in a novel, crystal form as an R(6) zinc hexamer at 2.3 A resolution, is essentially, identical to that of the wild-type R(6) hexamer. The variant side chain, remains buried in a nativelike crevice with small adjustments in, surrounding side chains. The corresponding photoactivatable analogue, although of low affinity, exhibits efficient cross-linking to the insulin, receptor. The site of photo-cross-linking lies within a 14 kDa C-terminal, domain of the alpha-subunit. This domain, unrelated in sequence to the, major insulin-binding region in the N-terminal L1 beta-helix, is also, contacted by photoactivatable probes at positions A8 and B25. Packing of, Val(A3) at this interface may require a conformational change in the B, chain to expose the A3-related crevice. The structure of insulin Wakayama, thus evokes the reasoning of Sherlock Holmes in "the curious incident of, the dog in the night": the apparent absence of structural perturbations, (like the dog that did not bark) provides a critical clue to the function, of a hidden receptor-binding surface.
Naturally occurring mutations in insulin associated with diabetes mellitus identify critical determinants of its biological activity. Here, we describe the crystal structure of insulin Wakayama, a clinical variant in which a conserved valine in the A chain (residue A3) is substituted by leucine. The substitution occurs within a crevice adjoining the classical receptor-binding surface and impairs receptor binding by 500-fold, an unusually severe decrement among mutant insulins. To resolve whether such decreased activity is directly or indirectly mediated by the variant side chain, we have determined the crystal structure of Leu(A3)-insulin and investigated the photo-cross-linking properties of an A3 analogue containing p-azidophenylalanine. The structure, characterized in a novel crystal form as an R(6) zinc hexamer at 2.3 A resolution, is essentially identical to that of the wild-type R(6) hexamer. The variant side chain remains buried in a nativelike crevice with small adjustments in surrounding side chains. The corresponding photoactivatable analogue, although of low affinity, exhibits efficient cross-linking to the insulin receptor. The site of photo-cross-linking lies within a 14 kDa C-terminal domain of the alpha-subunit. This domain, unrelated in sequence to the major insulin-binding region in the N-terminal L1 beta-helix, is also contacted by photoactivatable probes at positions A8 and B25. Packing of Val(A3) at this interface may require a conformational change in the B chain to expose the A3-related crevice. The structure of insulin Wakayama thus evokes the reasoning of Sherlock Holmes in "the curious incident of the dog in the night": the apparent absence of structural perturbations (like the dog that did not bark) provides a critical clue to the function of a hidden receptor-binding surface.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1XW7 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with ZN, CL and IPH as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1XW7 OCA].  
1XW7 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=CL:'>CL</scene> and <scene name='pdbligand=IPH:'>IPH</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1XW7 OCA].  


==Reference==
==Reference==
Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama., Wan ZL, Huang K, Xu B, Hu SQ, Wang S, Chu YC, Katsoyannis PG, Weiss MA, Biochemistry. 2005 Apr 5;44(13):5000-16. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=15794638 15794638]
Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama., Wan ZL, Huang K, Xu B, Hu SQ, Wang S, Chu YC, Katsoyannis PG, Weiss MA, Biochemistry. 2005 Apr 5;44(13):5000-16. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=15794638 15794638]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Chu, Y.C.]]
[[Category: Chu, Y C.]]
[[Category: Hu, S.Q.]]
[[Category: Hu, S Q.]]
[[Category: Huang, K.]]
[[Category: Huang, K.]]
[[Category: Katsoyannis, P.G.]]
[[Category: Katsoyannis, P G.]]
[[Category: Wan, Z.L.]]
[[Category: Wan, Z L.]]
[[Category: Weiss, M.A.]]
[[Category: Weiss, M A.]]
[[Category: Xu, B.]]
[[Category: Xu, B.]]
[[Category: CL]]
[[Category: CL]]
Line 30: Line 29:
[[Category: protein unfolding]]
[[Category: protein unfolding]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:11:40 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:59:15 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA